NCT05903430View on ClinicalTrials.gov

A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)

RecruitingOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

August 29, 2025

Primary Completion Date

January 29, 2027

Study Completion Date

January 29, 2027

Conditions
Abdominal CancerLung Cancer
Trial Locations (1)

M204BX

RECRUITING

The Christie NHS Foundation Trust, Manchester

All Listed Sponsors
lead

The Christie NHS Foundation Trust

OTHER

NCT05903430 - A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION) | Biotech Hunter | Biotech Hunter